|

RAS-antagonist and beta-blocker up-to maximal dosages Clinical Trials

1 actively recruiting trial

Also known as: Bisoprolol 10mg/d, Candesartan 32mg/d, Captopril 150mg/d, Carvedilol 50mg/d (100mg/d if weight is > 85kg), Cilazapril 5mg/d +15 more

Pipeline

Phase 4: 1

Top Sponsors

  • Martin Huelsmann1

Indications

  • Heart Disease1
  • Diabetes1
  • Heart Diseases1
  • Diabetes Mellitus, Type 21

Other1 trial

NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.